Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Technology Today.
Press releases published on July 22, 2025
NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025
GlobeNewswire
·
July 22, 2025
NAARDEN, the Netherlands and MIAMI, July 22, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
VisionWave Holdings, Inc. Debuts on Nasdaq with Goal of Accelerating AI-Driven Defense Technology Platform
GlobeNewswire
·
July 22, 2025
WEST HOLLYWOOD, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (“VisionWave” or the “Company”) (Nasdaq: VWAV), a next-generation defense technology company seeking to redefine battlefield superiority through AI-powered autonomy and …
American Rebel (NASDAQ: AREB) and American Rebel Light Beer Congratulate Matt Hagan on his Victory at the Muckleshoot Casino Resort NHRA Northwest Nationals
GlobeNewswire
·
July 22, 2025
Hagan, the four-time NHRA World Champion, recorded a string of strong runs in the NHRA Northwest Nationals to post his first 2025 NHRA Funny Car win Nashville, TN, July 22, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American …
AgEagle Aerial Systems eBee VISION Drone Receives Blue UAS Cleared Status
GlobeNewswire
·
July 22, 2025
Designation Allows for Direct, Expedited U.S. Government Procurement WICHITA, Kan., July 22, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging solutions, is proud to announce that its …
Rethinking R&D: BullFrog AI White Paper Outlines New Blueprint for Smarter Drug Development
GlobeNewswire
·
July 22, 2025
From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence In a $200B+ market crowded with black-box AI, BullFrog AI’s bfLEAP™ delivers what others can’t: biologically grounded, …
Electric Hydrogen receives DNV validation after the respected independent engineering firm’s comprehensive assessment of the company’s HYPRPlant
GlobeNewswire
·
July 22, 2025
DEVENS, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Electric Hydrogen, global manufacturer of high-power electrolyzer plants, announced today that DNV, the independent energy expert and assurance provider, has completed its comprehensive technical due …
SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification
GlobeNewswire
·
July 22, 2025
Tel Aviv, July 22, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous …
Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc.
GlobeNewswire
·
July 22, 2025
GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
GlobeNewswire
·
July 22, 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will …
BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET
GlobeNewswire
·
July 22, 2025
PALO ALTO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that it will release its second quarter …
Reunion Neuroscience Announces Publication of RE104 Phase 1 Data in The Journal of Clinical Psychopharmacology
GlobeNewswire
·
July 22, 2025
-- Phase 1 Data Highlight RE104 Favorable Safety Profile and Short Duration Psychoactive Experience -- -- Topline Results from RECONNECT Phase 2 Trial of RE104 in Postpartum Depression (PPD) Anticipated in Q3 2025 -- MORRISTOWN, N.J., July 22, 2025 (GLOBE …
ZenaTech’s ZenaDrone Subsidiary Applies for Green UAS Certification for IQ Square Drone to Sell to US Defense and Government
GlobeNewswire
·
July 22, 2025
VANCOUVER, British Columbia, July 22, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
Arch Biopartners Announces Start of Patient Recruitment in Phase II PONTIAK Trial Targeting Drug-Toxin-Related Acute Kidney Injury (AKI)
GlobeNewswire
·
July 22, 2025
TORONTO, July 22, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the investigator-led Phase II trial titled “Prevention Of NephroToxin Induced Acute Kidney Injury with …
Verifone and PagBrasil Launch Exclusive International Pix Payment Solution for Brazilian Shoppers in the U.S.
GlobeNewswire
·
July 22, 2025
NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- PagBrasil and Verifone have partnered to launch an in-store alternative payment method (APM) enabling Brazilian shoppers to pay in Brazilian Reais (BRL) using Pix while shopping in the United States. This first- …
Draganfly Secures Strategic Military Order for Commander 3XL UAV Systems
GlobeNewswire
·
July 22, 2025
Tampa Bay, Florida, July 22, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning developer of drone solutions and systems developer, today announced the sale of Commander 3XL …
uniQure to Announce Second Quarter 2025 Financial Results
GlobeNewswire
·
July 22, 2025
LEXINGTON, Mass. and AMSTERDAM, July 22, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report second quarter 2025 financial results before …
Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
GlobeNewswire
·
July 22, 2025
CAMBRIDGE, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on August 6, 2025 at 8:30 a.m. ET to …
ProMIS Neurosciences Announces Private Placement Financing
GlobeNewswire
·
July 22, 2025
TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 22, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to discovery and development of therapeutic antibodies targeting toxic misfolded …
FACIA Reports 100% Accuracy in Deepfake Detection Across Industry Datasets
GlobeNewswire
·
July 22, 2025
LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- FACIA, a global leader in facial biometric technology, announced that its deepfake detection system has achieved 100% accuracy on multiple industry datasets, including Meta’s Deepfake Detection Challenge Dataset ( …
Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation
GlobeNewswire
·
July 22, 2025
PRESS RELEASE Memo Therapeutics AG Publishes Study on its Potent Antibody for Treatment of BKPyV Infection in Kidney Transplantation Novel antibody, potravitug, demonstrates high neutralization of all BKPyV serotypes with potential to transform treatment …